264
Views
1
CrossRef citations to date
0
Altmetric
Open Peer Commentaries

Natural Talent, Fair Equality of Opportunity, and Therapeutic Use Exemptions

REFERENCES

  • Bougault, V., J. Turmel, and L. P. Boulet. 2010. Bronchial challenges and respiratory symptoms in elite swimmers and winter sport athletes: Airway hyperresponsiveness in asthma: its measurement and clinical significance. Chest 138 (2):31S–7S. doi:10.1378/chest.09-1689.
  • Eriksson, L. M., T. Irewall, A. Lindberg, and N. Stenfors. 2018. Prevalence, age at onset, and risk factors of self‐reported asthma among Swedish adolescent elite cross‐country skiers. Scandinavian journal of medicine & science in sports 28 (1):180–86. doi:10.1111/sms.12879.
  • Galston, W. A. 2011. Commonsense morality and the idea of nature. What we can learn from thinking about “Therapy”. In The ideal of nature: Debates about biotechnology and the environment, ed. G. E. Kaebnick, 168–78. Baltimore: Johns Hopkins University Press.
  • Heir, T., and S. Oseid. 1994. Self-reported asthma and exercise‐induced asthma symptoms in high‐level competitive cross‐country skiers. Scandinavian journal of medicine & science in sports 4 (2):128–33. doi:10.1111/j.1600-0838.1994.tb00415.x.
  • van Hilvoorde, I., R. Vos, and G. de Wert. 2007. Flopping, klapping and gene doping: Dichotomies between ‘natural'and ‘artificial’ in elite sport. Social studies of science 37 (2):173–200. doi:10.1177/0306312706063784.
  • Jacobsson, J., T. Timpka, J. Kowalski, S. Nilsson, J. Ekberg, Ö. Dahlström, and P. A. Renström. 2013. Injury patterns in Swedish elite athletics: Annual incidence, injury types and risk factors. Br J Sports Med 47 (15):941–52. doi:10.1136/bjsports-2012-091651.
  • Larsson, K., P. Ohlsen, L. Larsson, P. Malmberg, P. O. Rydström, and H. Ulriksen. 1993. High prevalence of asthma in cross country skiers. Bmj 307 (6915):1326–29. doi:10.1136/bmj.307.6915.1326.
  • Loland, S. 2018. Performance-enhancing drugs, sport, and the ideal of natural athletic performance. American Journal of Bioethics 18 (6):XX–XX.
  • World Anti-Doping Agency. 2015. World anti-doping code. International standard. therapeutic use exemptions. Montreal: World Anti-Doping Agency.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.